Search

Filters

Clear Filters
5:20 PM - 5:25 PM ET

1163 - Beyond NCCN: How a Prognostic and Predictive Multimodal AI Biomarker Drives ADT De-Escalation In Prostate Cancer
Speaker: Wegener, Eric, MBBS - Genesis Cancer Care, Newcastle, NSW
5:25 PM - 5:30 PM ET

1164 - Deep Genomic and Pathologic Profiling Reveals Treatment Modality-Specific Predictors of Biochemical Recurrence In Localized Prostate Cancer
Speaker: El-Sehemy, Ahmed, MD, PhD, MS, BS - University of Toronto, Toronto, ON
5:30 PM - 5:35 PM ET

1165 - Assessing MMAI Algorithmic Fairness within Racial and Age Subgroups In NRG/RTOG Post-Radical Prostatectomy Phase III Trials
Speaker: Moningi, Shalini, MD - Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
5:35 PM - 5:40 PM ET

1166 - Real-World Evidence across Prostate RT Modalities: Utilization Shifts, Toxicity and BCR in Genomic Classifier Scored Patients
Speaker: Kole, Thomas, MD, PhD - Memorial Sloan Kettering Monmouth, Middletown, NJ
5:40 PM - 5:45 PM ET

1168 - Germline Biomarker and Adverse Events following SBRT to the Prostate Fossa after Radical Prostatectomy
Speaker: Weidhaas, Joanne, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA
3:20 PM - 3:30 PM ET

117 - Addressing Global Gaps in Clinical Radiobiology Education: The IAEA e-Learning Solution for Radiation Oncology Professionals
Speaker: Tamaki, Tomoaki, MD, PhD - International Atomic Energy Agency (IAEA), Vienna, Vienna
5:25 PM - 5:30 PM ET

1170 - Evaluation of the Radiosensitivity Index and Genomic Adjusted Radiation Dose Framework in Cervical Cancer
Speaker: Ajao, Anuoluwapo, BS - Case Western Reserve School of Medicine, Cleveland, OH
5:30 PM - 5:35 PM ET

1171 - Association Between Plasma and Urine HPV Circulating Tumor DNA and Early Treatment Response in Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiation
Speaker: Vatanashevanopakorn, Chinnavuth, MD, PhD - Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkoknoi, Krung Thep
5:35 PM - 5:40 PM ET

1172 - Exploring the Association Between Pre-Treatment Cell Cycle Profiling and Chemoradiation Outcomes in Cervical Cancer
Speaker: Dahiya, Nilanjana, MD - Kidwai Memorial Institute of Oncology, Bangalore, Karnataka
5:40 PM - 5:45 PM ET

1173 - Morbidity of Pelvic Recurrence in Stage III Uterine Serous Carcinoma
Speaker: Lawlor, Mary-Kate, MD - Yale New Haven Health, New Haven, CT
5:45 PM - 5:50 PM ET

1174 - Five-Year Longitudinal Study of Quality of Life after Chemoradiotherapy Treatment of Cervical Cancer in Botswana
Speaker: Ross Brockman, Mae, None - University of North Carolina at Chapel Hill, Chapel Hill, NC
5:25 PM - 5:30 PM ET

1176 - Practice Variation In IMPT Treatment Planning in Oropharyngeal Cancer: Dose Differences and Expected Impact on Toxicity Outcome
Speaker: Langendijk, Johannes, MD, PhD - University Medical Center Groningen, Groningen, Groningen